Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours Β· Estimated delivery Aug 28 - Sep 2
Improves intestinal transit time and stool frequency
The free assessment quiz captures GI history including IBS, prior bowel surgery, and current medications that affect transit (opioids, anticholinergics)
Results: The 18-month risk for ION was 8.5 versus 5.5 per 10 000 among GLP-1RA users versus SGLT2i users (RD, 3.0 [95% CI, 0.4 to 5.7]) and 7.8 versus 4.2 per 10 000 among GLP-1RA users versus DPP4i users (RD, 3.6 [CI, 1.1 to 6.1])
Some can be very good for you, but many are contraindicated with anesthesia or surgery in general
This information helps you and your prescriber understand whether you're a strong, moderate, or sensitive responder to GLP-1 therapy, informing decisions about dose escalation and whether dual-compound formulas like GLP-Squared might enhance your results
